Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02248233 : Nimodipine for Treating Acute Massive Cerebral Infarction
PhasePhase 4
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

- First onset at age ? 80 years, no other severe medical complications;

- Clear consciousness or mild disturbance of consciousness; paralysis of upper and
lower extremities on one side with grade 0-3 muscle strength in paralyzed limbs;

- CT reveals early massive cerebral infarction (without cerebral hemorrhage or old
infarction);

- Blood pressure within, or higher than, the normal range.

Exclusion Criteria:

- Clinical manifestations are noticeably improved before treatment;

- Disorders of consciousness, manifesting as severe lethargy or coma;

- Mild neurological deficits, such as pure sensory disturbances, ataxia, dysarthria,
and hemiparesis;

- Severe hypotension (systolic pressure < 90 mmHg, diastolic pressure < 60 mmHg);

- Heart rate < 60 BPM; sinus bradycardia;

- Severe heart, brain or kidney dysfunction, or malignant tumor.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02248233      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740